You are here

Accelerated rTMS: A Potential Treatment Approach to Alleviate Depression?

×

Warning message

This Grand Rounds Webinar is restricted to registered participants or on-demand registrants. Click the following link to register: Register Here

Presenting: Accelerated rTMS: A Potential Treatment Approach to Alleviate Depression?

You’re invited to join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series:

Accelerated rTMS: A Potential Treatment Approach to Alleviate Depression?

Learning objectives: 

1.     Learners will know the most updated literature on accelerated rTMS paradigms and major depression.

2.     Learners will have better insights on the neurobiological effects of accelerated rTMS protocols applied in depressed patients.

3.     Learners will be able to state the risks and benefits of accelerated rTMS and accelerated iTBS paradigms for (treatment-resistant) major depression.

4.     Learners will be able to have improved risk and benefit discussions with (treatment-resistant) depressed patients who are interested in rTMS treatment.
 

Date: Tuesday, January 15, 2019

Format: On-Demand

Date of Release: January 16, 2019

Date of Expiration: January 15, 2021

Cost: Members: $25 | Non-members $50

 

Speakers: Chris Baeken, MD, PhD

Chris Baeken, MD, PhD is full time associate professor at the University hospital of the Ghent University, and he is part-time associate professor affiliated with the University hospital of the Free University of Brussels, both in Belgium. As a psychiatrist his main interests are within the neurobiological field of Affective Disorders. To gain more insight in the underlying mechanisms of emotional brain processes in the ‘healthy’ as well as in the ‘mentally affected’ human brain, brain-imaging paradigms (MRI, fMRI, (S)PET,….) are used with or without the combination of neuromodulation techniques, such as rTMS and tDCS. His scientific contributions to clinical neuroscience is shown by over 200 peer-refereed scientific publications, mainly on clinical treatment, brain stimulation and neurobiology. His work has received very high international recognition from peers as can be judged from over 3000 citations to his work and an H-index of 32 (Google Scholar).

Vertical Tabs

Vertical Tabs

Acknowledgement of Commercial Support
No financial or in-kind commercial support was received for this educational activity.

Stisfactory completion
Learners must complete an evaluation to receive a certificate of completion. You must participate in the entire webinar; partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.

Physicians         
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Clinical TMS Society.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Method of Physician Participation
Learners will listen to each audio self-directed module while following along with the visual slides. Upon completion, each learner will answer evaluation questions to receive their CE certificate.

Bibliographic Sources
See slides for bibliographic sources for further study.

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-­6.2, 6.5)

All individuals in a position to control the content of CE are listed below.

First Name

Last Name

Commercial Interest

Chris

Baeken

NA

Richard

Bermudes

American Psychiatric Association Publishing:Other

Bobbie

Fleming

NA

Sheryl

Morgan

NA

Please print all pages of your certificate for your record.
Questions? Email Certificate@AmedcoEmail.com